EUROFINS SCIENT Pre-Tax Income 2018-2024 | ERFSF
- EUROFINS SCIENT pre-tax income for the quarter ending June 30, 2024 was $0M, a 0% increase year-over-year.
- EUROFINS SCIENT pre-tax income for the twelve months ending June 30, 2024 was $0M, a 0% increase year-over-year.
- EUROFINS SCIENT annual pre-tax income for 2023 was $0.458B, a 44.25% decline from 2022.
- EUROFINS SCIENT annual pre-tax income for 2022 was $0.822B, a 34.26% decline from 2021.
- EUROFINS SCIENT annual pre-tax income for 2021 was $1.25B, a 57.59% increase from 2020.
EUROFINS SCIENT Annual Pre-Tax Income (Millions of US $) |
|
---|---|
2023 | $458 |
2022 | $822 |
2021 | $1,250 |
2020 | $793 |
2019 | $304 |
2018 | $342 |
2017 | $283 |
2016 | $2,762 |
2015 | $0 |
EUROFINS SCIENT Quarterly Pre-Tax Income (Millions of US $) |
|
---|---|
2024-06-30 | |
2023-06-30 | |
2022-12-31 | |
2021-12-31 | |
2021-06-30 | |
2020-12-31 | |
2020-06-30 | |
2019-12-31 | |
2019-06-30 | |
2018-12-31 | |
2018-06-30 | |
2017-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $11.063B | $7.522B |
Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $133.529B | 24.94 |
Elevance Health (ELV) | United States | $96.108B | 12.88 |
CVS Health (CVS) | United States | $84.839B | 12.41 |
Cencora (COR) | United States | $55.604B | 20.18 |
DiDi Global (DIDIY) | China | $20.317B | 29.86 |
Natera (NTRA) | United States | $20.018B | 0.00 |
BioMerieux (BMXMF) | France | $15.594B | 0.00 |
Solventum (SOLV) | United States | $11.463B | 10.69 |
ICON (ICLR) | Ireland | $11.251B | 10.22 |
Revvity (RVTY) | United States | $11.032B | 18.74 |
CochLear (CHEOY) | Australia | $10.876B | 0.00 |
Avantor (AVTR) | United States | $10.289B | 15.10 |
Doximity (DOCS) | United States | $9.934B | 51.66 |
Viatris (VTRS) | United States | $9.024B | 2.85 |
Medpace Holdings (MEDP) | United States | $8.956B | 23.46 |
Sonic Healthcare (SKHHY) | Australia | $7.706B | 0.00 |
HealthEquity (HQY) | United States | $7.311B | 35.97 |
Charles River Laboratories (CRL) | United States | $5.209B | 10.28 |
Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
Bausch + Lomb (BLCO) | Canada | $4.262B | 19.45 |
Alignment Healthcare (ALHC) | United States | $3.499B | 0.00 |
Sotera Health (SHC) | United States | $2.975B | 17.18 |
BrightSpring Health Services (BTSG) | United States | $2.905B | 30.18 |
Organon (OGN) | United States | $2.868B | 2.92 |
Surgery Partners (SGRY) | United States | $2.708B | 31.21 |
GeneDx Holdings (WGS) | United States | $2.680B | 318.23 |
Concentras Parent (CON) | United States | $2.613B | 13.59 |
Progyny (PGNY) | United States | $1.837B | 40.45 |
Ardent Health Partners (ARDT) | United States | $1.786B | 0.00 |
Premier (PINC) | United States | $1.765B | 11.30 |
GoodRx Holdings (GDRX) | United States | $1.720B | 37.38 |
Agilon Health (AGL) | United States | $1.649B | 0.00 |
PACS (PACS) | United States | $1.411B | 0.00 |
Teladoc Health (TDOC) | United States | $1.197B | 0.00 |
Pediatrix Medical (MD) | United States | $1.100B | 9.22 |
Ryman Healthcare (RYHTY) | New Zealand | $1.035B | 0.00 |
CareDx (CDNA) | United States | $0.977B | 16.62 |
Establishment Labs Holdings (ESTA) | $0.907B | 0.00 | |
Nutex Health (NUTX) | United States | $0.824B | 16.14 |
AMN Healthcare Services Inc (AMN) | United States | $0.706B | 5.59 |
Embecta (EMBC) | United States | $0.659B | 4.52 |
Auna S.A (AUNA) | Luxembourg | $0.515B | 13.65 |
QDM (QDMI) | Hong Kong, SAR China | $0.496B | 0.00 |
SBC Medicals (SBC) | United States | $0.417B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.405B | 0.00 |
Enhabit (EHAB) | United States | $0.388B | 36.57 |
InnovAge Holding (INNV) | United States | $0.372B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.290B | 0.00 |
LifeMD (LFMD) | United States | $0.242B | 0.00 |
DocGo (DCGO) | United States | $0.216B | 8.83 |
Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
Oncology Institute (TOI) | United States | $0.163B | 0.00 |
Sera Prognostics (SERA) | United States | $0.128B | 0.00 |
Beauty Health (SKIN) | United States | $0.106B | 0.00 |
So-Young (SY) | China | $0.084B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.082B | 0.00 |
OncoCyte (OCX) | United States | $0.081B | 0.00 |
Biodesix (BDSX) | United States | $0.080B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
NeueHealth (NEUE) | United States | $0.053B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
Pheton Holdings (PTHL) | China | $0.018B | 0.00 |
ModivCare (MODV) | United States | $0.014B | 4.93 |
Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
KindlyMD (KDLY) | United States | $0.011B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
Aclarion (ACON) | United States | $0.005B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
XWELL (XWEL) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |